DHR vs MDT
Danaher Corporation and Medtronic PLC, side by side — 10 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | DHR | MDT |
|---|---|---|
| Revenue | $24.6B | $36.4B |
| Net income | $3.6B | $4.8B |
| Gross margin | 59.1% | 65.0% |
| Net margin | 14.7% | 13.2% |
| Return on equity | 7.1% | 9.8% |
| Diluted EPS | $5.05 | $3.73 |
| Dividend / share | — | $2.84 |
| Payout ratio | 24.3% | 75.8% |
| Free cash flow | $5.3B | $5.4B |
| Equity | $52.5B | $49.5B |
| Net debt / equity | 0.26× | 0.53× |
| Current ratio | 1.87× | 2.13× |
| Revenue CAGR 5y | 2.0% | 3.8% |
| Profit CAGR 5y | −0.2% | 5.9% |
MDT bills 1.5× the revenue of DHR, and DHR keeps more of each dollar of revenue as profit (14.7% against 13.2%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
10 years side by side
| Fiscal year | DHR | MDT |
|---|---|---|
| FY2025 | $24.6B | $36.4B |
| FY2024 | $23.9B | $33.5B |
| FY2023 | $23.9B | $32.4B |
| FY2022 | $26.6B | $31.2B |
| FY2021 | $24.8B | $31.7B |
| FY2020 | $22.3B | $30.1B |
| FY2019 | $17.9B | $28.9B |
| FY2018 | $17.0B | $30.6B |
| FY2017 | $15.5B | $30.0B |
| FY2016 | $16.9B | $29.7B |
Net income by year
Bottom line
| Fiscal year | DHR | MDT |
|---|---|---|
| FY2025 | $3.6B | $4.8B |
| FY2024 | $3.9B | $4.7B |
| FY2023 | $4.8B | $3.7B |
| FY2022 | $7.2B | $3.8B |
| FY2021 | $6.4B | $5.0B |
| FY2020 | $3.6B | $3.6B |
| FY2019 | $3.0B | $4.8B |
| FY2018 | $2.7B | $4.6B |
| FY2017 | $2.5B | $3.1B |
| FY2016 | $2.6B | $4.0B |
Advertisement
AdSense · Rectangle 336×280